Related Experiment Video

Updated: Jul 11, 2026

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
08:43

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation

Published on: May 31, 2016

[The bone-vasculature-axis interaction: new insights into the pathogenesis of vascular calcification.]

M Cozzolino1, A Galassi, A Bellasi

  • 1U.O. Nefrologia e Dialisi, A.O. San Paolo, Cattedra di Nefrologia, Universita' degli Studi, Milano - Italy.

Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia
|September 22, 2007
PubMed

Insights

Cardiovascular disease in chronic kidney disease (CKD) is linked to vascular calcification (VC). Impaired mineral metabolism and low levels of inhibitory proteins like fetuin-A contribute to VC in CKD patients.

Area of Science:

  • Nephrology
  • Cardiology
  • Biochemistry

Background:

  • Cardiovascular disease is the leading cause of death in chronic kidney disease (CKD).
  • Vascular calcification (VC) is a key factor in cardiovascular morbidity and mortality among CKD patients.
  • Mineral metabolism disorders in CKD contribute to both renal osteodystrophy and extra-skeletal calcification.

Purpose of the Study:

  • To investigate the role of mineral metabolism disorders in CKD-related vascular calcification.
  • To explore the mechanisms of vascular smooth muscle cell mineralization in vitro.
  • To identify key inhibitory proteins that prevent VC in uremic conditions.

Main Methods:

  • In vitro studies examining the effects of high phosphate (P) and calcium (Ca) concentrations on vascular smooth muscle cells.
  • Analysis of the role of cell-mediated processes in VC.
  • Investigation of the impact of inhibitory proteins (fetuin-A, MGP, OPG, BMP-7) on VC.

Main Results:

  • High phosphate or calcium concentrations induce vascular smooth muscle cell mineralization in vitro.
  • VC involves an active, cell-mediated process alongside passive calcium-phosphate deposition.
  • Deficiency of inhibitory proteins like fetuin-A, MGP, OPG, and BMP-7 is critical in promoting VC in CKD.

Conclusions:

  • Mineral metabolism disorders significantly contribute to vascular calcification in CKD.
  • VC is an active cellular process exacerbated by imbalances in calcium and phosphate.
  • Preserving levels of inhibitory proteins is crucial for preventing vascular calcification in CKD patients.

More Related Videos

Analysis of Extracellular Vesicle-Mediated Vascular Calcification Using In Vitro and In Vivo Models09:01

Analysis of Extracellular Vesicle-Mediated Vascular Calcification Using In Vitro and In Vivo Models

Published on: January 27, 2023

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro11:30

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro

Published on: June 2, 2022

Related Concept Videos

Blood and Nerve Supply to the Bones01:29

Blood and Nerve Supply to the Bones

Bones are dynamic organs that require a rich supply of oxygen and nutrients. Around 5% to 10% of the cardiac output supplies blood to the bones. A typical long bone has three main sources: the nutrient artery, the metaphyseal and epiphyseal arteries, and the periosteal arteries.
Nutrient Artery
The nutrient artery is the main blood vessel that enters the diaphysis via the nutrient foramen. While most long bones have only one nutrient foramen, large bones, such as the femur, may have two. This...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
The Bone Matrix01:18

The Bone Matrix

Bone contains a relatively small number of cells entrenched in a matrix of collagen fibers that provide an adherent surface for inorganic salt crystals. Both components of the matrix, organic and inorganic, contribute to the unusual properties of bone. Without collagen, bones would be brittle and shatter easily. Without mineral crystals, bones would flex and provide little support. This can be observed by an experiment: when the minerals of a bone are dissolved by soaking the bone in acid or...
Role of Vitamins in Maintaining Bone Health01:25

Role of Vitamins in Maintaining Bone Health

The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...